Eldon C. Mayer III

Eldon C. Mayer III is a declared insider at 2 companies (chief executive); the most frequent names are Eiger BioPharmaceuticals, Inc. and Rigel Pharmaceuticals Inc. In total, 16 filings cover trades dated from 28 November 2001 to 17 March 2023.

In open-market terms, that means 8 purchases worth €806k on one side and 5 sales worth €36k on the other. On balance, insiders were net buyers of €770k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants. So far in 2023, the count stands at no purchases and 2 sales.

Half of the purchases are above €65k and half below. 4 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 21 March 2023: an open-market sale of €1,890, in Eiger BioPharmaceuticals, Inc. The latest purchase dates back some time: it was published 2,458 days ago, on 30 January 2020. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.